Virios Therapeutics, Inc. (NASDAQ:VIRI – Get Free Report)’s share price shot up 14.2% during trading on Monday . The stock traded as high as $2.70 and last traded at $2.65. 135,376 shares were traded during mid-day trading, a decline of 87% from the average session volume of 1,049,645 shares. The stock had previously closed at $2.32.
Virios Therapeutics Stock Performance
The company has a market cap of $49.69 million, a PE ratio of -9.56 and a beta of 1.58. The company has a 50 day simple moving average of $1.77 and a two-hundred day simple moving average of $2.00.
About Virios Therapeutics
Virios Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for fibrotic diseases. The company leverages its proprietary small-molecule platform to identify and advance compounds designed to modulate key pathways involved in scar formation and tissue repair. By concentrating on conditions with high unmet medical need, Virios aims to improve patient outcomes through more effective and safer treatment options.
The company’s lead development candidate, VTI-1002, is an oral small molecule inhibitor in clinical trials for the prevention and treatment of hypertrophic scars and keloids.
Further Reading
- Five stocks we like better than Virios Therapeutics
- The Pentagon’s Grok Rollout Puts These 3 Stocks in Focus
- Copper Surges as Shifting Trade Policy and AI Demand Collide
- Ulta Beauty’s Earnings Beat Was Stronger Than the Stock’s Reaction
- Bancorp’s Fintech Comeback Gains Momentum
Receive News & Ratings for Virios Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virios Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
